Evidence map›Paper›PMID 41982595›Full record

ArticleCureus2026

Cervical Cancer Screening in Women Living With HIV in Suriname.

Lycke Woittiez, Andjanie Soekdew, Els Dams, Kees Brinkman, Jimmy Roosblad, Michèle van Vugt, Stephen G Vreden

Abstract read
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Lycke WoittiezInternal Medicine, Academic Hospital Paramaribo, Paramaribo, SUR.
Andjanie SoekdewFaculty of Medicine, University of Amsterdam, Amsterdam, NLD.
Els DamsInternal Medicine, Diakonessenhuis, Paramaribo, SUR.
Kees BrinkmanInternal Medicine, Onze Lieve Vrouwen Gasthuis, Amsterdam, NLD.
Jimmy RoosbladClinical Chemistry, Academic Hospital Paramaribo, Paramaribo, SUR.
Michèle van VugtInfectious Diseases, Amsterdam University Medical Center, Amsterdam, NLD.
Stephen G VredenInternal Medicine, Foundation for the Advancement of Scientific Research in Suriname, Paramaribo, Suriname.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Suriname has an estimated human immunodeficiency virus (HIV) prevalence of 1.6% among adults aged 15 to 49 years. Women living with HIV (WLWH) have a higher risk of developing cervical cancer or dysplasia. The World Health Organization (WHO) guidelines advise cervical screening once every three years, starting at age 25, when using visual inspection with acetic acid (VIA). Objective The primary objective of this study was to determine how often WLWH in Suriname undergo cervical screening. The secondary objective was to explore factors associated with cervical screening participation. Methodology In this single-center study, data were collected from all WLWH visiting the HIV outpatient clinic of the Academic Hospital Paramaribo during six weeks in 2023. The last cervical screening date was registered. To explore factors associated with the cervical screening rate, these women were asked to fill out a questionnaire. Results During the study period, 195 WLWH visited the outpatient department. Of these, 134 (68.7%) had ever gone for cervical screening, and 77 (39.5%) had gone for cervical screening in the past three years. A total of 134 WLWH participated in the questionnaire. Of those women, 99 (73.9%) were not aware of the higher risk of cervical cancer in WLWH. Conclusions Although a majority of WLWH had done cervical screening at least once in their lives, less than 40% were screened in the last three years in accordance with WHO guidelines. Strategies to increase the number of women going for cervical cancer screening should be explored in the coming years.

Indexed as

cervical cancerhivscreeningsurinamewlwh

Identifiers

PMID41982595
PMCPMC13075976

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.